Zhejiang Huahai Pharmaceutical Co., Ltd. (600521.SS)
- Previous Close
14.35 - Open
14.30 - Bid 14.29 x --
- Ask 14.30 x --
- Day's Range
14.17 - 14.37 - 52 Week Range
13.49 - 21.55 - Volume
14,298,331 - Avg. Volume
19,426,022 - Market Cap (intraday)
21.563B - Beta (5Y Monthly) 0.52
- PE Ratio (TTM)
18.10 - EPS (TTM)
0.79 - Earnings Date --
- Forward Dividend & Yield 0.20 (1.39%)
- Ex-Dividend Date Jul 10, 2024
- 1y Target Est
--
Zhejiang Huahai Pharmaceutical Co., Ltd. operates as a pharmaceutical company in China and internationally. The company offers central neurological, cardiovascular, anti-viral, and other products, as well as APIs and intermediates. It also provides packaging components, such as high-density polyethylene bottles and polypropylene caps for pharmaceuticals. In addition, the company offers contract manufacturing and other services, as well as import and export trade services. The company was founded in 1989 and is headquartered in Linhai, China.
www.huahaipharm.com--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Recent News: 600521.SS
View MorePerformance Overview: 600521.SS
Trailing total returns as of 5/14/2025, which may include dividends or other distributions. Benchmark is SSE Composite Index (000001.SS) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 600521.SS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 600521.SS
View MoreValuation Measures
Market Cap
21.64B
Enterprise Value
27.00B
Trailing P/E
18.16
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
2.21
Price/Book (mrq)
2.21
Enterprise Value/Revenue
2.87
Enterprise Value/EBITDA
16.06
Financial Highlights
Profitability and Income Statement
Profit Margin
12.16%
Return on Assets (ttm)
4.76%
Return on Equity (ttm)
12.28%
Revenue (ttm)
9.42B
Net Income Avi to Common (ttm)
1.15B
Diluted EPS (ttm)
0.79
Balance Sheet and Cash Flow
Total Cash (mrq)
2.35B
Total Debt/Equity (mrq)
77.94%
Levered Free Cash Flow (ttm)
-755.89M